Re: perspective China

According to the white paper, as of June 2016, the General Administration of food and Drug Administration of China has a total of 176652 articles of domestic drug approval, of which 3517 of the drug approval for children, accounting for 2% of the total number of the drugs. Among them, proprietary Chinese medicine accounted for 68.5%, chemical drugs accounted for 31.5%. From the point of view of drug therapy, it mainly focuses on respiratory system and gastrointestinal system, and there are few indications for other fields. "This shows that the area of treatment for existing pediatric drugs is narrow." Zhang Buyong, general manager of punctuation Medical Information Co., Ltd.
academician of Chinese Academy of engineering and Li Lianda, an expert in pharmacology of Chinese medicine, told the news weekly of "lookout" that there is a misunderstanding that children are "small adults", and that pediatric medicine is the half and reduction of medicine, which is wrong. Because children have their growth and development laws and physiological and pathological characteristics, children have special characteristics in the occurrence, development and prognosis of diseases. "Even if children and adults have the same disease, their development patterns are different. The prescriptions, precautions and medication rules are different."

Wang Xiaoling said that as a result of the "lack of medicine" in pediatrics, the number of people aged 5~14 years old in our country is likely to die of preventable and treatable diseases as many as 100 thousand. "125 children are poisoned and poisoned every day in the world. Poisoning is also the main cause of injury and death among children in China."

children's drug safety report 2015 shows that in children, drug poisoning accounts for the proportion of all poisoned children, from 53% in 2012 to 73% in 2014. From this data, "the injury to children is more serious." Wang Xiaoling said.

children's drug poisoning is mostly caused by misuse. This means that the drug instructions are very important for pediatric medication safety. Wang Xiaoling said that at present, the drug instructions in China are still quite chaotic, and the data of pharmacokinetics of children are seriously insufficient. "We hope that the country will be able to require enterprises to put up the latest pharmaceutical instructions on the official website, even the database of drug instructions in the developed countries, as well as a comprehensive evaluation system for children's clinical medication and an active monitoring system for children's adverse reactions, and the establishment of a children's pharmacokinetic database to allow children to use drugs. More and more reliable scientific information and basis. "